Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 17 |
GO:0110165 | cellular anatomical entity | 1 | 17 |
Related structures:
AlphaFold database: A4HDV3
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 17 |
GO:0008104 | protein localization | 4 | 17 |
GO:0009987 | cellular process | 1 | 17 |
GO:0015031 | protein transport | 4 | 17 |
GO:0016192 | vesicle-mediated transport | 4 | 17 |
GO:0033036 | macromolecule localization | 2 | 17 |
GO:0045184 | establishment of protein localization | 3 | 17 |
GO:0051179 | localization | 1 | 17 |
GO:0051234 | establishment of localization | 2 | 17 |
GO:0051641 | cellular localization | 2 | 17 |
GO:0070727 | cellular macromolecule localization | 3 | 17 |
GO:0071702 | organic substance transport | 4 | 17 |
GO:0071705 | nitrogen compound transport | 4 | 17 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 114 | 118 | PF00082 | 0.442 |
CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.449 |
DEG_APCC_DBOX_1 | 113 | 121 | PF00400 | 0.161 |
DEG_APCC_DBOX_1 | 141 | 149 | PF00400 | 0.641 |
DOC_MAPK_MEF2A_6 | 142 | 150 | PF00069 | 0.667 |
DOC_PP1_RVXF_1 | 20 | 27 | PF00149 | 0.597 |
LIG_14-3-3_CanoR_1 | 92 | 98 | PF00244 | 0.432 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.666 |
LIG_deltaCOP1_diTrp_1 | 23 | 33 | PF00928 | 0.570 |
LIG_eIF4E_1 | 140 | 146 | PF01652 | 0.646 |
LIG_FHA_1 | 25 | 31 | PF00498 | 0.606 |
LIG_FHA_1 | 72 | 78 | PF00498 | 0.321 |
LIG_LIR_Gen_1 | 102 | 112 | PF02991 | 0.313 |
LIG_LIR_Gen_1 | 67 | 76 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 102 | 107 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 18 | 24 | PF02991 | 0.619 |
LIG_LIR_Nem_3 | 47 | 51 | PF02991 | 0.330 |
LIG_NRBOX | 116 | 122 | PF00104 | 0.246 |
LIG_NRP_CendR_1 | 151 | 152 | PF00754 | 0.473 |
LIG_Pex14_2 | 104 | 108 | PF04695 | 0.328 |
LIG_Rb_pABgroove_1 | 82 | 90 | PF01858 | 0.422 |
LIG_REV1ctd_RIR_1 | 18 | 26 | PF16727 | 0.547 |
LIG_SH2_CRK | 127 | 131 | PF00017 | 0.272 |
LIG_SH2_CRK | 59 | 63 | PF00017 | 0.251 |
LIG_SH2_STAP1 | 127 | 131 | PF00017 | 0.351 |
LIG_SH2_STAP1 | 133 | 137 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 99 | 102 | PF00017 | 0.316 |
LIG_SUMO_SIM_anti_2 | 73 | 79 | PF11976 | 0.351 |
LIG_TYR_ITIM | 125 | 130 | PF00017 | 0.291 |
LIG_WRC_WIRS_1 | 65 | 70 | PF05994 | 0.367 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.282 |
MOD_CK1_1 | 70 | 76 | PF00069 | 0.256 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.476 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.172 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.318 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.341 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.264 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.303 |
MOD_N-GLC_1 | 93 | 98 | PF02516 | 0.402 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.575 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.323 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.283 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.282 |
MOD_NEK2_2 | 99 | 104 | PF00069 | 0.323 |
MOD_PIKK_1 | 24 | 30 | PF00454 | 0.646 |
MOD_PKA_2 | 141 | 147 | PF00069 | 0.665 |
MOD_Plk_1 | 22 | 28 | PF00069 | 0.622 |
MOD_Plk_1 | 93 | 99 | PF00069 | 0.351 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.316 |
MOD_Plk_4 | 141 | 147 | PF00069 | 0.581 |
MOD_Plk_4 | 41 | 47 | PF00069 | 0.324 |
MOD_Plk_4 | 64 | 70 | PF00069 | 0.303 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.325 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.297 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.245 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.251 |
TRG_ER_diArg_1 | 150 | 152 | PF00400 | 0.609 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5I1 | Leptomonas seymouri | 34% | 69% |
A0A0N0P8A7 | Leptomonas seymouri | 80% | 100% |
A0A0N1I3M5 | Leptomonas seymouri | 27% | 86% |
A0A0N1I5N1 | Leptomonas seymouri | 31% | 90% |
A0A0S4JF33 | Bodo saltans | 50% | 96% |
A0A0S4JFY8 | Bodo saltans | 34% | 97% |
A0A1X0NLN3 | Trypanosomatidae | 32% | 89% |
A0A1X0P315 | Trypanosomatidae | 36% | 90% |
A0A1X0P7F6 | Trypanosomatidae | 53% | 98% |
A0A1X0P987 | Trypanosomatidae | 31% | 72% |
A0A3Q8IBK0 | Leishmania donovani | 88% | 100% |
A0A3S5H567 | Leishmania donovani | 40% | 70% |
A0A3S5H5K3 | Leishmania donovani | 34% | 93% |
A0A422MRP4 | Trypanosoma rangeli | 55% | 97% |
A0A422N175 | Trypanosoma rangeli | 32% | 86% |
A0A422NC91 | Trypanosoma rangeli | 34% | 89% |
A0A422NJC0 | Trypanosoma rangeli | 34% | 90% |
A4H3Q4 | Leishmania braziliensis | 38% | 70% |
A4HRX8 | Leishmania infantum | 40% | 70% |
A4HSK3 | Leishmania infantum | 34% | 93% |
A4I148 | Leishmania infantum | 88% | 100% |
C9ZJ62 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 98% |
C9ZU90 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 92% |
D0A8W1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 88% |
E9ACN7 | Leishmania major | 40% | 70% |
E9AJX6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 70% |
E9AKI7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 93% |
E9AX82 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
O95562 | Homo sapiens | 32% | 95% |
P38166 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 29% | 71% |
Q4FZV2 | Rattus norvegicus | 37% | 97% |
Q4QA90 | Leishmania major | 86% | 100% |
Q4QJC1 | Leishmania major | 36% | 100% |
Q5SSN7 | Mus musculus | 33% | 96% |
Q5U3Y5 | Rattus norvegicus | 33% | 96% |
Q8VD57 | Mus musculus | 37% | 96% |
Q8WV19 | Homo sapiens | 32% | 96% |